Literature DB >> 1111552

A possible association between the nucleoside transport system of human erythrocytes and adenosine deaminase.

R P Agarwal, R E Parks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1111552     DOI: 10.1016/0006-2952(75)90146-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  7 in total

1.  Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  R P Agarwal; G W Crabtree; R E Parks; J A Nelson; R Keightley; R Parkman; F S Rosen; R C Stern; S H Polmar
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

2.  Purine metabolism of erythrocytes in myotonic dystrophy.

Authors:  M M Müller; R Kuzmits; M Frass; B Mamoli
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

3.  Surface expression of adenosine deaminase in mitogen-stimulated lymphocytes.

Authors:  M Martin; J J Centelles; J Huguet; F Echevarne; D Colomer; J L Vives-Corrons; R Franco
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

4.  Adenosine deaminase activity associated with phagocytic vacuoles. Cytochemical demonstration by electron microscopy.

Authors:  G L Tritsch; N S Paolini; K Bielat
Journal:  Histochemistry       Date:  1985

5.  Adenosine uptake in pyrimidine 5'-nucleotidase deficient human erythrocytes via a high affinity transport system.

Authors:  T Kagimoto; S Tomino; K Takatsuki
Journal:  Experientia       Date:  1985-03-15

6.  Cosolvent-buffer mixtures as models for the cytoplasmic mileu: the enzymology of adenosine aminohydrolase.

Authors:  G L Tritsch; P R Niswander; J Rosenfeld; A Nechaev; A Mittelman
Journal:  Mol Cell Biochem       Date:  1976-08-30       Impact factor: 3.396

7.  Ecto-enzyme activity of human erythrocyte adenosine deaminase.

Authors:  K Bielat; G L Tritsch
Journal:  Mol Cell Biochem       Date:  1989-04-11       Impact factor: 3.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.